Grindr to buy HIV prevention telehealth firm Freddie for $250mn
Grindr has agreed to acquire PurposeMed, the company behind HIV prevention service Freddie, for $250 million in cash and stock. According to a statement released on Wednesday, Grindr will pay $190 million in cash and $60 million in shares. An additional $70 million in cash is contingent on Freddie achieving specific targets in 2027. The deal is expected to close by the end of this year.
This marks Grindr’s first major acquisition since its launch in 2009.
Integrating PrEP into the Grindr App
Freddie, founded in Canada in 2020, offers Pre-Exposure Prophylaxis (PrEP), a daily pill that prevents HIV, along with testing and home delivery services, all accessible online. With over 55,000 patients served, the company has expanded to the US in 2024, covering all 50 states.
Grindr, boasting nearly 16 million monthly users, plans to integrate Freddie directly into its app. “Grindr has a direct line to millions of gay men, and Freddie brings the medical expertise to turn that reach into care,” stated George Arison, Grindr’s CEO.
Dr Husein Moloo, co-founder and CEO of Freddie, expressed the deal's potential to bring care to millions more individuals: “Inside the app they already use every day; it could ‘speed up the work of ending the HIV epidemic.’”
Building on Existing Services
This acquisition follows Grindr’s launch of Woodwork, an erectile dysfunction service in 2025. The company plans to merge these services into a single offering called Grindr Health.
Health data privacy has been a sensitive issue for Grindr. In 2024, UK users sued the company, claiming it shared their HIV status with advertisers. Grindr denied ever selling health data.